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Background: Venom hyaluronidase (Hyase) contributes to the diffusion of venom from the inoculation site. In this
work, we purified and characterized Hyase from the venom of Vitalius dubius (Araneae, Theraphosidae), a large
theraphosid found in southeastern Brazil. Venom obtained by electrical stimulation of adult male and female
V. dubius was initially fractionated by gel filtration on a Superdex® 75 column. Active fractions were pooled and
applied to a heparin-sepharose affinity column. The proteins were eluted with a linear NaCl gradient.
Results: Active fractions were pooled and assessed for purity by SDS-PAGE and RP-HPLC. The physicochemical tests
included optimum pH, heat stability, presence of isoforms, neutralization by flavonoids and assessment of commercial
antivenoms. Hyase was purified and presented a specific activity of 148 turbidity-reducing units (TRU)/mg (venom: 36
TRU/mg; purification factor of ~4). Hyase displayed a molecular mass of 43 kDa by SDS-PAGE. Zymography in
hyaluronic-acid-containing gels indicated an absence of enzyme isoforms. The optimum pH was 4-5, with highest
activity at 37°C. Hyase was stable up to 60°C; but its activity was lost at higher temperatures and maintained after
several freeze-thaw cycles. The NaCl concentration (up to 1 M) did not influence activity. Hyase had greater action
towards hyaluronic acid compared to chondroitin sulfate, and was completely neutralized by polyvalent antiarachnid
sera, but not by caterpillar, scorpion or snakes antivenoms.
Conclusion: The neutralization by arachnid but not scorpion antivenom indicates that this enzyme shares antigenic
epitopes with similar enzymes in other spider venoms. The biochemical properties of this Hyase are comparable to
others described.
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Spider venoms comprise complex mixtures of compo-
nents of low molecular weight, peptides and proteins
[1]. Among the enzymatic activities, collagenase and hy-
aluronidase (Hyase) are often found and were formerly
attributed to matrix degradation [1].
Hyase activity is found in several spider species, such
as Cupiennius salei, Lycosa godeffroy, Lampona cylin-
drata/murina, Loxosceles recluse, Loxosceles rufescens,
Loxosceles deserta, Loxosceles gaucho, Loxosceles laeta,
Loxosceles recluse, and Loxosceles intermedia [1-6]. The* Correspondence: thomaz.silva@fcmsantacasasp.edu.br
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reproduction in any medium, provided the orfirst report of hyaluronidasic activity was in venoms of
the Brazilian spiders Lycosa raptorial and Phoneutria
nigriventer [7,8]. The first Hyase to be purified from a
Theraphosidae spider was the one from the tarantula
Dugesiella hentzi (Girard), which was characterized and
identified as the major venom component [9].
The clinical relevance of Hyases is not confined to a
toxin-spreading factor, since it acts as an allergen in a
manner similar to hymenoptera venoms. Hyase, phospho-
lipase A2 and melitin were identified as the tree major
causes of allergic reactions involved in bee stings, and
phospholipase A1 and antigen 5 are the major allergens in
wasp venoms [10,11].
Although tarantula bites to humans are relatively rare
[12-14], these spider venoms represent a rich source ofd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Comparison of hyaluronidase activity present in the
venom of V. dubius and P. nigriventer. The values represent the
mean ± S.E. (n = 6).
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and possible therapeutic applications [15-18].
The tarantula Vitalius dubius (Mello-Leitão, 1923) is
characterized as nonaggressive and is found in the very
populous area of southeastern Brazil [19]. Recent studies
have shown that V. dubius venom has a complex bio-
chemical and pharmacological composition, with differ-
ent biological activities [20,21]. In the present work we
describe the purification and characterization of the hy-
aluronidase present in its venom.
Methods
Reagents
Refined chemicals were purchased from Sigma Chemical
Co. (USA) whereas heparin was purchased from Labora-
tório Cristália (Brazil). Molecular mass markers for SDS-
PAGE were acquired from BioRad (USA). The resins for
column chromatography were purchased from GE Health-
care Life Sciences (Sweden). The HPLC column was a
Jupiter C18 (4.6 mm × 250 mm × 12 μm) acquired from
Phenomenex (USA).
Spiders and venom extraction
Specimens of V. dubius and Phoneutria nigriventer were
provided by the Centers for Zoonosis Control for the
cities in the region of Campinas, São Paulo state. The
spiders were identified and kept in captivity, where they
were fed cockroaches and water ad libitum. The taran-
tula venom was extracted as described by Rocha-e-Silva
et al. [20] then lyophilized and stored at−80°C until use.
Antisera
We used six antivenom sera produced by the Butantan
Institute in São Paulo: (1) antiarachnid (Phoneutria
nigriventer, Loxosceles gaucho and Tityus serrulatus); (2)
antiscorpionic (T. serrulatus); (3) antilonomic (Lonomia
obliqua); (4) antibothropic (Bothrops alternatus, B. jar-
araca, B. jararacussu, B. moojeni and B. neuwiedi); (5)
anticrotalic (Crotalus durissus terrificus and Crotalus
durissus collilineatus); and (6) antielapidic (Micrurus
frontalis and M. corallinus).
Enzymatic activity
Hyaluronidase activity was determined by a turbidimet-
ric method [22]. The working solution for this trial con-
sisted of a 200 μL buffer (0.2 M sodium acetate, pH 6.0,
containing 0.15 M NaCl), 200 μL of substrate (hyalur-
onic acid from human umbilical cord 1 mg/mL in acet-
ate buffer) and 100 μL of enzyme (20 μg) to give a total
reaction volume of 500 μL. This mixture was incubated
for 15 minutes at 37°C after which the reaction was
stopped by adding 2 mL of hexadecyltrimethylammo-
nium bromide in 2.5% NaOH. The resulting turbidity
was read at 400 nm in a SpectraMax® 340 microplatereader (Molecular Devices, USA) after 30 minutes of in-
cubation at room temperature. One unit of activity cor-
responded to the amount of enzyme that produced a
50% reduction in turbidity caused by 200 μg of substrate
under the conditions described above.
Purification of Hyaluronidase
The venom (10 mg) of V. dubius was dissolved in 0.1 M
sodium acetate buffer, pH 6.0, containing 0.15 M NaCl,
and fractionated by a Superdex® 75 gel filtration column
(10 mm × 30 cm) balanced and eluted with the same
buffer. Fractions of 1.5 mL each were collected at a flow
rate of 1 mL per minute using an ÄKTA-Purifier chro-
matographic system (Pharmacia, Sweden). The elution
profile was determined by monitoring the absorbance at
280 nm.
The hyaluronidase-containing fractions eluted from
the previous step were applied to a heparin-sepharose
column equilibrated with 0.1 M sodium acetate buffer,
pH 6.0. The fractions were washed and eluted under a
gradient of NaCl (0 to 1.0 M). The elution profile was
determined by monitoring the absorbance at 280 nm
whereas fractions (1.5 mL) containing the enzyme were
stored at 8°C.
Hyase purity was evaluated by RP-HPLC chromatog-
raphy using a resource RPC column (4.6 mm × 250 mm ×
12 μm). The column was balanced with 0.1% trifluoracetic
acid (TFA) and the enzyme was eluted with a linear gradi-
ent (0-100%) of 66% acetonitrile in 0.1% TFA. The elution
profile was monitored at 280 nm.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
zymography
Electrophoresis was performed using 12% acrylamide or
5-20% gradients gels [23]. The existence of isoforms of
Figure 2 Hyaluronidase purification from the venom of V. dubius. (A) Gel filtration chromatography on Superdex® G-75 showing three active
fractions. (B) Positive fractions from the previous step were applied to an affinity column of heparin-Sepharose (5 mL). The enzyme was detected
at peak 2 (arrow), not retained by column. (C) C-18 reversed phase chromatography for final purification, using ACN gradient. (D) Left: SDS-PAGE
of crude venom (Vd) and purified Hyase (Hy), using polyacrylamide gel 12% stained with silver nitrate. The estimated mass for the enzyme was
43 kDa. Right: crude venom and purified enzyme zymography. M =molecular weight markers.
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[24]. The hyaluronic acid was mixed into the SDS-
polyacrylamide gels to obtain a final concentration of
0.6 mg/mL of non-polymerized solution.
During zymography, the electrophoretic separation phase
was performed under the same conditions previously de-
scribed (gels, buffers etc.), except for the samples, that were
not warmed, to conserve their enzymatic activities. After
Stains all staining (Sigma-Aldrich Co.), the gel was washed
with a buffer containing 0.015 M Tris–HCl, 5% formamide
and 20% isopropyl alcohol, pH 7.9, and photo documented.
Physicochemical characterization of the enzyme
The optimum pH was determined by changing the
buffers of the enzymatic turbidimetric assay as follows:
0.1 M sodium citrate, pH 3.0 to 6.0, 0.1 M sodium acet-
ate, pH 4.0 to 6.0 and 0.1 M Tris–HCl, pH 5.5 to 8.0
(0.15 M NaCl was added to all buffers).The optimal working temperature of the enzyme was
evaluated by adjusting assay temperature between 10
and 70°C. The thermal stability of the enzyme was tested
by pre-incubating enzyme solution for 15 minutes under
a temperature ranging from 25 to 80°C.
To evaluate freezing longevity of the enzyme, sepa-
rated aliquots were stored at−20°C and enzyme activity
measured at the times 1, 2, 3, 6, 24, 72 hours and 7 and
15 days. Each aliquot was thawed once before the
assay. To evaluate freezing cycles stability, a stock so-
lution was stored, then thawed and refrozen for each
enzyme assay, following same intervals in the freezing
longevity test.
We investigated substrate specificity of the enzyme to-
wards hyaluronic acid and chondroitin sulfate A. For this
assay the Hyase activity was measured by quantifying
the released sugars according to the colorimetric method
of Reissig et al. [25].
Figure 4 Stability of purified Hyase after freeze-thaw cycles
(−20°C): the activity remained at maximum after the first three
freeze-thaw cycles (0, 1 and 3 hours), with a slight decrease
after six hours, unchanged until 15 days. Aliquots maintained
their activity until the seventh day, losing activity after 15 days of
freezing. The points represent mean ± SEM (n = 6), * p < 0.05.
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concentration that results in the half of the maximum vel-
ocity (Km) were assessed with fixed amounts of enzyme and
variable substrate concentrations. The N-acetylamine re-
lease was quantified by the method of Reissig et al. [25].
The parameters were calculated using Lineweaver-Burk
graphs, as previously described by Segel [26].
Immunological comparisons
An ELISA test was used to assess cross-reactivity be-
tween the enzyme and the commercial sera against sev-
eral venomous species of spiders, scorpions and snakes.
The ability of Instituto Butantan’s commercial anti-
venom to neutralize the enzymatic activity of V. dubius
was assessed using the turbidimetric assay. The enzyme
was pre-incubated with different volumes of each anti-
venom for 30 minutes at 37°C before measuring the
enzyme activity. Control assays were performed using
venom only.
Statistics
The results were expressed as the mean ± SEM for the
number of assays. Statistical comparisons were made
using ANOVA followed by the Tukey test, with p < 0.05
indicating significance.
Results
The Hyase activity of V. dubius venom was lower than
that of P. nigriventer (with respective turbidities of 11.6
and 5.6%). The venom of P. nigriventer reached assay sat-
uration at a concentration of 5 μg/mL, while V. dubius
venom showed maximum activity at 15 μg/mL (Figure 1).
Hyase purification was initiated through a size ex-
clusion chromatography, which provided three activeFigure 3 Properties of hyaluronidase from V. dubius. The
purified enzyme showed maximum activity at pH between 4 and 5
and temperature from 35 and 40°C. Lower activity was observed
starting from 25°C, decreasing gradually from 45°C onwards with
total loss above 60°C. The points represent the mean ± S.E. (n = 6).fractions (fractions 7, 8 and 9), pooled for the second
stage (Figure 2A). In the following affinity chromatography,
Hyase activity was detected in one fraction (Figure 2B)
(fraction 5). Reversed-phase HPLC provided the purified
Hyase (Figure 2C). The enzyme purity was confirmed by a
12% SDS-PAGE and zymography, which showed only one
band around 43 kDa (Figure 2D).
About 850 μg of purified Hyase was obtained from
18 mg of crude venom protein, with an activity corre-
sponding to 19.5% of the venom. The total activity sig-
nificantly dwindled in the second stage (from 615.3 TRU
to 124.4), but the specific activity augmented gradually
during the purification process (148 U/mg). The purifi-
cation factor had also increased (4.1).Figure 5 Enzymatic activity of V. dubius venom (10 μg) and
purified Hyase (5 μg) on hyaluronic acid and chondroitin
sulfate A. The points represent mean ± SEM (n = 6).
Figure 6 Lineweaver-Burk graphs (1/S vs. 1/V) to Hyase Vmax
and Km determination using hyaluronic acid as substrate.
The points represent mean ± SEM (n = 6).
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of the purified enzyme showed maximum activity at pH
between 4 and 5 and temperature from 35 and 40°C.
Lower activity was observed at 25°C, decreasing gradually
from 45°C onwards with total loss above 60°C (Figure 3).
Enzyme samples submitted to consecutive freeze-thaw
cycles remained at maximum activity after the first three
cycles (0, 1 and 3 hours), with a slight decrease after six
hours, remaining stable until 15 days. Otherwise, individual
frozen aliquots maintained their activity until the seventh
day, losing activity after 15 days of freezing (Figure 4).
The substrate specificity was evaluated in both purified
enzyme and crude venom; it was observed that the
Hyase has a higher specificity to hyaluronic acid, but a
lower activity in the presence of chondroitin (Figure 5).
The values obtained for Vmax and Km from V. dubius-
purified Hyase were 11.4 μg/min and 677.0 μg/mL,
respectively, as shown in Figure 6.Figure 7 Immunological comparisons. (A) Dose-dependent neutralizatio
bothropic, anticrotalic and antielapidic sera were inefficient at neutralizing
purified Hyase (5 μg) compared to anti-arachnidic serum on ELISA. The poiAntiophidic, antiscorpionic and antilonomic serum
were inefficient at neutralizing the enzymatic activity
(Figure 7A). The antiarachnid serum against enzyme and
crude venom neutralized Hyase activity in a dose-
dependent manner (Figure 7B).
Discussion
The hyaluronidases (Hyases) that have been isolated
from various sources and extensively characterized com-
prise a group of enzymes described as 4-hyaluronate glu-
canohydrolase (EC 3.2.1.35, hyaluronoglucosamidase),
hyaluronate-3-glucanohydrolase (EC 3.2.1.36, hyalurono-
glucuronidase) and hyaluronatelyase (EC 4.2.2.1) [27].
The presence of this enzyme has been described in several
human tissues, animal venoms, pathogenic organisms and
cancers. Animal venom Hyases are structurally similar to
those from the acrosome membrane of sperm, which play a
fundamental role in mammalian fertilization, and to Hyases
Hyal-1 and Hyal-2 of mammalian lysosomes [28-30]. Thus,
venom Hyases are attributed the scattering function by
facilitating the spread of toxins through glucosamine glycan
hydrolysis in connective tissue, thereby yielding systemic
poisoning [31].
As expected, the venom of P. nigriventer presents higher
Hyase activity than that of V. dubius, due to the former’s
abundant high-molecular-weight molecules, thus requir-
ing a higher permeability to promote the dissemination of
such components [1]. Moreover, the venom of V. dubius
has few components of high molecular weight, but rather
a predominance of low-weight molecules, such as pep-
tides, thus less need of Hyase [20].
That molecular profile of V. dubius Hyase venom con-
tributed to the enzyme purification process. In three
chromatographic steps, we obtained the pure enzyme,
while in the venoms from other animals–namely Tityus
serrulatus, Buthus martensi, Apis mellifera, Vespula vul-
garis, Synanceja horrida and Lonomia obliqua–moren of Hyase by anti-arachnidic serum. Antiscorpionic, antilonomic, anti-
the enzymatic activity. (B) Reactivity of V. dubius venom (10 μg) and
nts represent mean ± SEM (n = 6).
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cation [11,27,28,32-34].
The enzyme yield (4.8%) was considered low after purifi-
cation, mainly because the enzyme is present at small con-
centrations in the total venom. Similar yields (4.9%) can
be obtained during the Hyase purification of the scorpion
venom of Tityus serrulatus [27]. Otherwise, the purifica-
tion from the venom of the scorpion Palamneus gravima-
nus, provided a higher yield, about 40% [31].
The optimum working temperature of purified V.
dubius Hyase is around 37°C, which matches the physio-
logical range of some of its largest prey, such as small
rodents [35]. The enzyme loses its activity at 60°C, per-
haps due to losses in the molecular structure, thus com-
promising its activity. Same hyaluronidase temperature
range can be found in the venom activity presented by
Agkistrodon contortrix and Tityus serrulatus [27,36].
The optimum pH found in V. dubius Hyase was be-
tween 4 and 5, the same described for Buthus martensi
and Palamneus gravimanus enzymes [31,32]. In the
Hyase of Hippasa partita, the best pH was observed to
be 6 [37]. The finding of a pH between 4 and 5 can be
explained by the preferential degradation of an acid sub-
strate by the enzyme.
The V. dubius Hyase has a Km of 677.0 μg/mL, indi-
cating a comparatively low affinity of the substrate for
the enzyme catalytic site, in contrast to the Hyases of T.
serrulatus (69.7 μg/mL) and P. gravimanus (47.61 μg/
mL) scorpions, but similar to the stonefish Synanceja
horrida (709 μg/mL) [27,31,33].
Testing the specificity of substrates, we observed that
V. dubius Hyase exerts greater activity on hyaluronic
acid compared to chondroitin, although still positive for
the latter. The chondroitin test was positive for bovine
hyaluronidase but negative for Hyases purified from the
venoms of Hippasa partita and Agkistrodon contortrix
[36,37].
The neutralization of Hyase activity by antivenoms has
not been widely studied. The experiments conducted in
our laboratory showed that the venom Hyase of V.
dubius was recognized by antiarachnid serum, in a dose-
dependent manner. The lack of influence of the antiscor-
pionic sera, obtained from Tytius venoms that are used
for antiarachnid production, attest that the above
neutralization is specifically due to antibodies raised
against Loxosceles and Phoneutria sp., pooled for anti-
venom preparation against the latter. Neutralization also
failed with antilonomic and antisnake sera, reinforcing
the reaction specificity of V. dubius Hyase against spider
antivenoms. This indicates that immunological identities
may differ between the Hyase of arachnids and those of
snakes and caterpillars. This immunological relationship
has also been reported for several other enzymes and
toxins of venoms [38].Conclusions
Based on these findings, we conclude that the venom of
V. dubius contains a Hyase with physicochemical and
biochemical characteristics similar to other Hyases of
venoms, although less potent. Nevertheless, the studied
Hyase shares immunological features specifically with
other spiders’ enzymes, rather than those of caterpillars
and snakes.
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